Evidence map›Paper›PMID 33374269›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Simultaneous Quantification of Antioxidants Paraxanthine and Caffeine in Human Saliva by Electrochemical Sensing for CYP1A2 Phenotyping.

Rozalia-Maria Anastasiadi, Federico Berti, Silvia Colomban, Claudio Tavagnacco, Luciano Navarini, Marina Resmini

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rozalia-Maria AnastasiadiDepartment of Chemistry, Queen Mary University of London, Mile End Road, London E1 4NS, UK.
Federico BertiDepartment of Chemical and Pharmaceutical Sciences, University of Trieste, via L. Giorgieri 1, 34127 Trieste, Italy.ORCID 0000-0001-5608-3798
Silvia ColombanAromalab, illycaffè S.p.A., Area Science Park, Localita' Padriciano 99, 34149 Trieste, Italy.ORCID 0000-0001-6081-1452
Claudio TavagnaccoDepartment of Chemical and Pharmaceutical Sciences, University of Trieste, via L. Giorgieri 1, 34127 Trieste, Italy.
Luciano NavariniAromalab, illycaffè S.p.A., Area Science Park, Localita' Padriciano 99, 34149 Trieste, Italy.ORCID 0000-0002-9539-7500
Marina ResminiDepartment of Chemistry, Queen Mary University of London, Mile End Road, London E1 4NS, UK.ORCID 0000-0001-8109-5352

Funding

H2020 Marie Skłodowska-Curie Actions Grant Agreement no. 642014 (IPCOS).
6 · The paper itself

Abstract

The enzyme CYP1A2 is responsible for the metabolism of numerous antioxidants in the body, including caffeine, which is transformed into paraxanthine, its main primary metabolite. Both molecules are known for their antioxidant and pro-oxidant characteristics, and the paraxanthine-to-caffeine molar ratio is a widely accepted metric for CYP1A2 phenotyping, to optimize dose-response effects in individual patients. We developed a simple, cheap and fast electrochemical based method for the simultaneous quantification of paraxanthine and caffeine in human saliva, by differential pulse voltammetry, using an anodically pretreated glassy carbon electrode. Cyclic voltammetry experiments revealed for the first time that the oxidation of paraxanthine is diffusion controlled with an irreversible peak at ca. +1.24 V (vs. Ag/AgCl) in a 0.1 M H

Indexed as

antioxidantscaffeineCYP1A2 phenotypingdifferential pulse voltammetryhuman salivaparaxanthine

Identifiers

PMID33374269
PMCPMC7823619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.